Pulse Biosciences: Precision Strikes in the Nanosecond Range: How the Company is Revolutionizing Medicine
Reading Time: 3 minutes
Pulse Biosciences has developed a highly precise, non-thermal method called Nanosecond Pulsed Field Ablation , which targets and destroys diseased cells using electrical impulse waves without harming surrounding tissue. Using the profitable razor-and-blades model, the company generates continuously recurring revenue with high gross margins through specialized disposable medical equipment and usage-based software fees after selling the CellFX consoles. While the planned foray into the billion-dollar cardiology market for the treatment of atrial...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

